Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
š¼
SK
SIGN UP
SIGN IN
ENTITY
SMARTSCORE: 3/5
Insulet Corp (PODD US)
Watchlist
Contact IR
83
Analysis
Health Care
ā¢
United States
Insulet Corporation is a medical device company that develops, manufactures and markets an insulin infusion system for people with insulin-dependent diabetes.
more
Watchlist
Contact IR
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
ā¢
Benefit One Inc
ā¢
19 Nov 2023 01:44
Weekly Deals Digest (19 Nov) - Benefit One, JBR, Eoflow, Haitong, Vinda, Asahi, Tata Tech, Zeekr
Last week, notable developments occurred in Event-Driven (Benefit One, JBR, Eoflow, Celltrion Healthcare, Haitong Intl., Vinda, OreCorp, Amara,...
Arun George
Follow
569 Views
Share
bullish
ā¢
Pasona Group
ā¢
18 Nov 2023 23:05
Last Week in Event SPACE: Zhejiang, Pasona, ENN Energy, Asahi Group, Azure Minerals
The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...
David Blennerhassett
Follow
580 Views
Share
bullish
ā¢
Benefit One Inc
ā¢
18 Nov 2023 23:00
(Mostly) Asia-Pac Weekly Risk Arb Wrap: Benefit One, Japan Best Rescue System, IJTT, Ohizumi, VNET
This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...
David Blennerhassett
Follow
571 Views
Share
bullish
ā¢
Eoflow
ā¢
16 Nov 2023 02:06
EOFlow Craters. Medtronic Stays Mum
Shares have given up all of this year's outperformance. That looks like arb investors have chucked in the towel. It's not pretty. And the situation...
David Blennerhassett
Follow
709 Views
Share
bearish
ā¢
Eoflow
ā¢
15 Nov 2023 13:27
EOFLOW/Medtronic Tender: Trading Suspension Lifted, Now for the Hard Part
The shares should rise on trading resumption due to Medtronic's tender remaining in play and the short-selling ban-driven market rally. However,...
Arun George
Follow
922 Views
Share
First
Previous
3
4
5
6
7
8
9
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright Ā© 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.58.0
x